Literature DB >> 33666272

Macrophage Heterogeneity in NASH: More Than Just Nomenclature.

Gopanandan Parthasarathy1, Harmeet Malhi1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33666272      PMCID： PMC8662756          DOI： 10.1002/hep.31790

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  8 in total

1.  Niche-Specific Reprogramming of Epigenetic Landscapes Drives Myeloid Cell Diversity in Nonalcoholic Steatohepatitis.

Authors:  Jason S Seidman; Ty D Troutman; Mashito Sakai; Anita Gola; Nathanael J Spann; Hunter Bennett; Cassi M Bruni; Zhengyu Ouyang; Rick Z Li; Xiaoli Sun; BaoChau T Vu; Martina P Pasillas; Kaori M Ego; David Gosselin; Verena M Link; Ling-Wa Chong; Ronald M Evans; Bonne M Thompson; Jeffrey G McDonald; Mojgan Hosseini; Joseph L Witztum; Ronald N Germain; Christopher K Glass
Journal:  Immunity       Date:  2020-05-01       Impact factor: 31.745

Review 2.  Macrophage heterogeneity in liver injury and fibrosis.

Authors:  Frank Tacke; Henning W Zimmermann
Journal:  J Hepatol       Date:  2014-01-08       Impact factor: 25.083

3.  Impaired Kupffer Cell Self-Renewal Alters the Liver Response to Lipid Overload during Non-alcoholic Steatohepatitis.

Authors:  Sophie Tran; Ines Baba; Lucie Poupel; Sébastien Dussaud; Martine Moreau; Adélaïde Gélineau; Geneviève Marcelin; Elissa Magréau-Davy; Melissa Ouhachi; Philippe Lesnik; Alexandre Boissonnas; Wilfried Le Goff; Björn E Clausen; Laurent Yvan-Charvet; Florian Sennlaub; Thierry Huby; Emmanuel L Gautier
Journal:  Immunity       Date:  2020-06-19       Impact factor: 31.745

4.  Lipid-Associated Macrophages Control Metabolic Homeostasis in a Trem2-Dependent Manner.

Authors:  Diego Adhemar Jaitin; Lorenz Adlung; Christoph A Thaiss; Assaf Weiner; Baoguo Li; Hélène Descamps; Patrick Lundgren; Camille Bleriot; Zhaoyuan Liu; Aleksandra Deczkowska; Hadas Keren-Shaul; Eyal David; Niv Zmora; Shai Meron Eldar; Nir Lubezky; Oren Shibolet; David A Hill; Mitchell A Lazar; Marco Colonna; Florent Ginhoux; Hagit Shapiro; Eran Elinav; Ido Amit
Journal:  Cell       Date:  2019-06-27       Impact factor: 41.582

5.  A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis.

Authors:  Scott L Friedman; Vlad Ratziu; Stephen A Harrison; Manal F Abdelmalek; Guruprasad P Aithal; Juan Caballeria; Sven Francque; Geoffrey Farrell; Kris V Kowdley; Antonio Craxi; Krzysztof Simon; Laurent Fischer; Liza Melchor-Khan; Jeffrey Vest; Brian L Wiens; Pamela Vig; Star Seyedkazemi; Zachary Goodman; Vincent Wai-Sun Wong; Rohit Loomba; Frank Tacke; Arun Sanyal; Eric Lefebvre
Journal:  Hepatology       Date:  2018-01-29       Impact factor: 17.425

6.  Stellate Cells, Hepatocytes, and Endothelial Cells Imprint the Kupffer Cell Identity on Monocytes Colonizing the Liver Macrophage Niche.

Authors:  Johnny Bonnardel; Wouter T'Jonck; Djoere Gaublomme; Robin Browaeys; Charlotte L Scott; Liesbet Martens; Bavo Vanneste; Sofie De Prijck; Sergei A Nedospasov; Anna Kremer; Evelien Van Hamme; Peter Borghgraef; Wendy Toussaint; Pieter De Bleser; Inge Mannaerts; Alain Beschin; Leo A van Grunsven; Bart N Lambrecht; Tom Taghon; Saskia Lippens; Dirk Elewaut; Yvan Saeys; Martin Guilliams
Journal:  Immunity       Date:  2019-09-24       Impact factor: 31.745

7.  Resolving the fibrotic niche of human liver cirrhosis at single-cell level.

Authors:  P Ramachandran; R Dobie; J R Wilson-Kanamori; E F Dora; B E P Henderson; N T Luu; J R Portman; K P Matchett; M Brice; J A Marwick; R S Taylor; M Efremova; R Vento-Tormo; N O Carragher; T J Kendall; J A Fallowfield; E M Harrison; D J Mole; S J Wigmore; P N Newsome; C J Weston; J P Iredale; F Tacke; J W Pollard; C P Ponting; J C Marioni; S A Teichmann; N C Henderson
Journal:  Nature       Date:  2019-10-09       Impact factor: 49.962

8.  Osteopontin Expression Identifies a Subset of Recruited Macrophages Distinct from Kupffer Cells in the Fatty Liver.

Authors:  Anneleen Remmerie; Liesbet Martens; Tinne Thoné; Angela Castoldi; Ruth Seurinck; Benjamin Pavie; Joris Roels; Bavo Vanneste; Sofie De Prijck; Mathias Vanhockerhout; Mushida Binte Abdul Latib; Lindsey Devisscher; Anne Hoorens; Johnny Bonnardel; Niels Vandamme; Anna Kremer; Peter Borghgraef; Hans Van Vlierberghe; Saskia Lippens; Edward Pearce; Yvan Saeys; Charlotte L Scott
Journal:  Immunity       Date:  2020-09-03       Impact factor: 31.745
  8 in total
  3 in total

Review 1.  Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH).

Authors:  Xiaohan Xu; Kyle L Poulsen; Lijuan Wu; Shan Liu; Tatsunori Miyata; Qiaoling Song; Qingda Wei; Chenyang Zhao; Chunhua Lin; Jinbo Yang
Journal:  Signal Transduct Target Ther       Date:  2022-08-13

2.  MiR-690 treatment causes decreased fibrosis and steatosis and restores specific Kupffer cell functions in NASH.

Authors:  Hong Gao; Zhongmou Jin; Gautam Bandyopadhyay; Karina Cunha E Rocha; Xiao Liu; Huayi Zhao; Dinghong Zhang; Hani Jouihan; Soheil Pourshahian; Tatiana Kisseleva; David A Brenner; Wei Ying; Jerrold M Olefsky
Journal:  Cell Metab       Date:  2022-06-13       Impact factor: 31.373

Review 3.  Iron Metabolism and Immune Regulation.

Authors:  Shuo Ni; Yin Yuan; Yanbin Kuang; Xiaolin Li
Journal:  Front Immunol       Date:  2022-03-23       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.